Avalign And Subsidiary Instrumed To Pay $9.5M In Uncleared Device Settlement
Executive Summary
Avalign Technologies is paying $9.5m to settle fraud charges. The company and its Instrumed International subsidiary sold unapproved devices that they falsely claimed held pre-amendment status.